Tentang Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
Kantor pusatCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Berdiri2013
StatusAktif
Paten60 paten
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Masuk untuk melihat semua 60 paten
Telusuri seluruh portofolio paten, lengkap dengan nomor publikasi, tanggal, dan famili paten.
Masuk Buat akun dengan email AndaGratis
Dengan melanjutkan, Anda menyetujui Perjanjian Pengguna, Kebijakan Privasi, dan Kebijakan Cookie Heelky.
Ulasan
Belum ada ulasan. Pernah bekerja dengan Onyx Pharmaceuticals, Inc.? Jadilah yang pertama membagikan pengalaman Anda.
Informasi hukum
| Nama hukum | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Lihat di GLEIF ↗ |
| Alamat terdaftar | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Aktif |
Sumber: GLEIF · diperbarui 16 Okt. 2026
Kontak & tautan
Lokasi
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Apakah ini perusahaan Anda?
Klaim halaman ini gratis untuk menambahkan logo, produk, foto, dan pekerjaan, serta menjawab ulasan.
Klaim halaman iniBergabung dengan Heelky untuk terhubung, merekrut, dan berkembang
Buat akun gratis untuk mengirim pesan, melamar pekerjaan, dan memposting misi.
Gabung sekarang — gratis